| [1] |
McDonagh TA, Metra M, Adamo M, et al. 2023 Focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure[J]. Eur Heart J, 2023, 44(37):3627-3639.
DOI
URL
|
| [2] |
Schefold JC, Filippatos G, Hasenfuss G, et al. Heart failure and kidney dysfunction:epidemiology,mechanisms and management[J]. Nat Rev Nephrol, 2016, 12(10):610-623.
DOI
PMID
|
| [3] |
Abraham J, Blumer V, Burkhoff D, et al. Heart failure-related cardiogenic shock:pathophysiology,evaluation and management considerations:review of heart failure-related cardiogenic shock[J]. J Card Fail, 2021, 27(10):1126-1140.
DOI
PMID
|
| [4] |
赵旭, 王伟, 赵小静, 等. 慢性心力衰竭患者出入量管理的最佳证据总结[J]. 中华护理杂志, 2020, 55(3):456-461.
DOI
|
|
Zhao X, Wang W, Zhao XJ, et al. Best evidence summary for management of output and input in chronic heart failure patients[J]. Chin J Nurs, 2020, 55(3):456-461.
DOI
|
| [5] |
张海燕, 裴源源, 高伟波, 等. Ⅰ型心肾综合征的发病机制及诊断标志物的研究进展[J]. 中华急诊医学杂志, 2024, 33(3):442-448.
|
|
Zhang HY, Pei YY, Gao WB, et al. Research progress on pathogenesis and diagnostic markers of typeⅠcardiorenal syndrome[J]. Chin J Emerg Med, 2024, 33(3):442-448.
|
| [6] |
Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure:a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines[J]. J Am Coll Cardiol, 2022, 79(17):e263-e421.
DOI
PMID
|
| [7] |
Ezekowitz JA, O’Meara E, McDonald MA, et al. 2017 Comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure[J]. Can J Cardiol, 2017, 33(11):1342-1433.
DOI
PMID
|
| [8] |
Voors AA, Mulder H, Reyes E, et al. Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction:insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) trial[J]. Eur J Heart Fail, 2021, 23(8):1313-1321.
DOI
URL
|
| [9] |
王蔚云, 刘长红, 孙国珍, 等. 累积液体平衡量对心力衰竭患者容量状态影响的研究[J]. 中华护理杂志, 2024, 59(14):1691-1698.
|
|
Wang WY, Liu CH, Sun GZ, et al. The influence of cumulative fluid balance on volume status in patients with heart failure[J]. Chin J Nurs, 2024, 59(14):1691-1698.
|
| [10] |
黎永艳, 张海霞, 邱棋伟. 水分测定仪测定食品中水分的含量[J]. 医学动物防制, 2011, 27(9):880-881.
|
|
Li YY, Zhang HX, Qiu QW. Determination water content in food by moisture test apparatus[J]. J Med Pest Contr, 2011, 27(9):880-881.
|
| [11] |
O’Donnell LJ, Virjee J, Heaton KW. Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate[J]. BMJ, 1990, 300(6722):439-440.
DOI
PMID
|
| [12] |
Casa DJ, Armstrong LE, Hillman SK, et al. National athletic trainers’ association position statement:fluid replacement for athletes[J]. J Athl Train, 2000, 35(2):212-224.
|
| [13] |
Strauss MB, Davis RK, Rosenbaum JD, et al. Water diuresis produced during recumbency by the intravenous infusion of isotonic saline solution[J]. J Clin Invest, 1951, 30(8):862-868.
DOI
PMID
|
| [14] |
中国医师协会肾脏内科医师分会心肾综合征指南工作组. 心肾综合征诊疗的临床实践指南(2023版)[J]. 中华医学杂志, 2023, 103(46):3705-3759.
|
|
Cardiorenal Syndrome Guidelines Working Group of Chinese Nephrologist Association of Chinese Medical Doctor Association. Clinical practice guideline for the diagnosis and treatment of cardiorenal syndrome(2023 edition)[J]. Natl Med J China, 2023, 103(46):3705-3759.
|
| [15] |
张宇扬, 李庆印, 张琳彦, 等. 心肾综合征患者容量管理护理方案的构建[J]. 中国护理管理, 2024, 24(10):1564-1569.
|
|
Zhang YY, Li QY, Zhang LY, et al. Construction of nursing protocol on volume management in patients with cardio-renal syndrome[J]. Chin Nurs Manag, 2024, 24(10):1564-1569.
|
| [16] |
Boorsma EM, Ter Maaten JM, Damman K, et al. Congestion in heart failure:a contemporary look at physiology,diagnosis and treatment[J]. Nat Rev Cardiol, 2020, 17(10):641-655.
DOI
PMID
|
| [17] |
Oida M, Hasumi E, Kohsaku G, et al. The estimated glomerular filtration rate predicts pacemaker-induced cardiomyopathy[J]. Sci Rep, 2023, 13(1):16514.
DOI
|
| [18] |
Teragawa H, Tanaka A, Takahashi K, et al. Impact of baseline left ventricular ejection fraction and body mass index on the effect of 24-week Ipragliflozin treatment on left ventricular diastolic function in patients with type 2 diabetes and chronic kidney disease:insights from the PROCEED trial[J]. Cardiovasc Diabetol, 2025, 24(1):190.
DOI
|
| [19] |
Shen ZY, Zhang YP, Yang C, et al. A smart-phone app for fluid balance monitoring in patients with heart failure:a usability study[J]. Patient Prefer Adherence, 2022, 16:1843-1853.
DOI
URL
|
| [20] |
Höög L, Strömberg A, Waldréus N, et al. Insights into clinical practice:a national survey on fluid intake management in heart failure[J]. ESC Heart Fail, 2025, 12(4):2769-2779.
|
| [21] |
王蔚云, 刘长红, 黄艳玲, 等. 慢性心力衰竭患者个体化液体摄入管理方案的构建与应用研究[J]. 中华护理杂志, 2021, 56(12):1772-1778.
DOI
|
|
Wang WY, Liu CH, Huang YL, et al. Construction and application of an individualized management scheme of fluid intake for patients with chronic heart failure[J]. Chin J Nurs, 2021, 56(12):1772-1778.
DOI
|
| [22] |
Johansson P, van der Wal MH, Strömberg A, et al. Fluid restriction in patients with heart failure:how should we think?[J]. Eur J Cardiovasc Nurs, 2016, 15(5):301-304.
DOI
URL
|
| [23] |
王蔚云, 顾则娟, 黄艳玲, 等. 限制液体摄入对心力衰竭患者预后影响的系统评价[J]. 中华现代护理杂志, 2021, 27(32):4407-4414.
|
|
Wang WY, Gu ZJ, Huang YL, et al. A systematic review of the effects of limited fluid intake on the prognosis of patients with heart failure[J]. Chin J Mod Nurs, 2021, 27(32):4407-4414.
|
| [24] |
Herrmann JJ, Rocca HB, Baltussen LEHJM, et al. Liberal fluid intake versus fluid restriction in chronic heart failure:a randomized clinical trial[J]. Nat Med, 2025, 31(6):2062-2068.
DOI
|
| [25] |
罗桢蓝, 胡三莲, 朱凌燕, 等. 慢性心力衰竭患者自我容量管理的最佳证据总结[J]. 中华护理杂志, 2022, 57(7):880-886.
DOI
|
|
Luo ZL, Hu SL, Zhu LY, et al. Evidence summary for self volume-management in patients with chronic heart failure[J]. Chin J Nurs, 2022, 57(7):880-886.
DOI
|
| [26] |
Holst M, Strömberg A, Lindholm M, et al. Liberal versus restricted fluid prescription in stabilised patients with chronic heart failure:result of a randomised cross-over study of the effects on health-related quality of life,physical capacity,thirst and morbidity[J]. Scand Cardiovasc J, 2008, 42(5):316-322.
DOI
URL
|
| [27] |
Haydock PM, Flett AS. Management of heart failure with reduced ejection fraction[J]. Heart, 2022, 108(19):1571-1579.
DOI
PMID
|
| [28] |
Bozkurt B, Mullens W, Leclercq C, et al. Cardiac rhythm devices in heart failure with reduced ejection fraction-role,timing,and optimal use in contemporary practice. European Journal of Heart Failure expert consensus document[J]. Eur J Heart Fail, 2025, 27(7):1242-1261.
DOI
PMID
|
| [29] |
McCallum W, Tighiouart H, Testani JM, et al. Rates of reversal of volume overload in hospitalized acute heart failure:association with long-term kidney function[J]. Am J Kidney Dis, 2022, 80(1):65-78.
|
| [30] |
Marenzi G, Lauri G, Guazzi M, et al. Cardiac and renal dysfunction in chronic heart failure:relation to neurohumoral activation and prognosis[J]. Am J Med Sci, 2001, 321(6):359-366.
PMID
|
| [31] |
Fowler LH, McAtee C. Cardiorenal syndromes:evaluation and management[J]. Crit Care Nurs Clin North Am, 2022, 34(4):383-393.
|
| [32] |
Ronco C, Kaushik M, Valle R, et al. Diagnosis and management of fluid overload in heart failure and cardio-renal syndrome:the “5B” approach[J]. Semin Nephrol, 2012, 32(1):129-141.
DOI
URL
|